Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 1 | United Kingdom | 15 Oct 2020 |